Literature DB >> 20308571

Gonadotropin-positive pituitary tumors accompanied by ovarian tumors in aging female ERbeta-/- mice.

Xiaotang Fan1, Chiara Gabbi, Hyun-Jin Kim, Guojun Cheng, Leif C Andersson, Margaret Warner, Jan-Ake Gustafsson.   

Abstract

At 2 years of age, 100% (23/23) of ERbeta(-/-) female mice have developed large pituitary and ovarian tumors. The pituitary tumors are gonadotropin-positive and the ovarian tumors are sex cord (less differentiated) and granulosa cell tumors (differentiated and estrogen secreting). No male mice had pituitary tumors and no pituitary or ovarian tumors developed in ERalpha(-/-) mice or in ERalphabeta(-/-) double knockout mice. The tumors have high proliferation indices, are ERalpha-positive, ERbeta-negative, and express high levels of nuclear phospho-SMAD3. Mice with granulosa cell tumors also had hyperproliferative endometria. The cause of the pituitary tumors appeared to be excessive secretion of gonadotropin releasing hormone (GnRH) from the hypothalamus resulting from high expression of NPY. The ovarian phenotype is similar to that seen in mice where inhibin is ablated. The data indicate that ERbeta plays an important role in regulating GnRH secretion. We suggest that in the absence of ERbeta, the proliferative action of FSH/SMAD3 is unopposed and the high proliferation leads to the development of ovarian tumors. The absence of tumors in the ERalphabeta(-/-) mice suggests that tumor development requires the presence of ERalpha.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20308571      PMCID: PMC2851950          DOI: 10.1073/pnas.1002029107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  48 in total

Review 1.  Molecular biology of the pituitary gonadotropins.

Authors:  S D Gharib; M E Wierman; M A Shupnik; W W Chin
Journal:  Endocr Rev       Date:  1990-02       Impact factor: 19.871

2.  Cloning of a novel receptor expressed in rat prostate and ovary.

Authors:  G G Kuiper; E Enmark; M Pelto-Huikko; S Nilsson; J A Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

3.  Divergent effects of estradiol on gonadotropin gene transcription in pituitary fragments.

Authors:  M A Shupnik; S D Gharib; W W Chin
Journal:  Mol Endocrinol       Date:  1989-03

4.  Sex steroid hormone regulation of follicle-stimulating hormone subunit messenger ribonucleic acid (mRNA) levels in the rat.

Authors:  S D Gharib; M E Wierman; T M Badger; W W Chin
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

5.  Tumor repressive functions of estrogen receptor beta in SW480 colon cancer cells.

Authors:  Johan Hartman; Karin Edvardsson; Karolina Lindberg; Chunyan Zhao; Cecilia Williams; Anders Ström; Jan-Ake Gustafsson
Journal:  Cancer Res       Date:  2009-07-14       Impact factor: 12.701

6.  Cloning of the human estrogen receptor cDNA.

Authors:  P Walter; S Green; G Greene; A Krust; J M Bornert; J M Jeltsch; A Staub; E Jensen; G Scrace; M Waterfield
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

Review 7.  Estrogen signaling: a subtle balance between ER alpha and ER beta.

Authors:  Jason Matthews; Jan-Ake Gustafsson
Journal:  Mol Interv       Date:  2003-08

8.  Estrogen receptor beta regulates epithelial cellular differentiation in the mouse ventral prostate.

Authors:  Otabek Imamov; Andrea Morani; Gil-Jin Shim; Yoko Omoto; Christina Thulin-Andersson; Margaret Warner; Jan-Ake Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-08       Impact factor: 11.205

9.  Estrogen suppresses rat gonadotropin gene transcription in vivo.

Authors:  M A Shupnik; S D Gharib; W W Chin
Journal:  Endocrinology       Date:  1988-05       Impact factor: 4.736

10.  Estrogen alters the effects of neuropeptide-Y on luteinizing hormone and follicle-stimulating hormone release in female rats at the level of the anterior pituitary gland.

Authors:  M J Woller; G T Campbell; L Liu; R W Steigerwalt; C A Blake
Journal:  Endocrinology       Date:  1993-12       Impact factor: 4.736

View more
  10 in total

Review 1.  Pathogenesis of pituitary tumors.

Authors:  Shlomo Melmed
Journal:  Nat Rev Endocrinol       Date:  2011-03-22       Impact factor: 43.330

2.  The putative G-protein coupled estrogen receptor agonist G-1 suppresses proliferation of ovarian and breast cancer cells in a GPER-independent manner.

Authors:  Cheng Wang; Xiangmin Lv; Chao Jiang; John S Davis
Journal:  Am J Transl Res       Date:  2012-10-10       Impact factor: 4.060

Review 3.  Minireview: animal models and mechanisms of ovarian cancer development.

Authors:  Lisa K Mullany; JoAnne S Richards
Journal:  Endocrinology       Date:  2012-03-06       Impact factor: 4.736

Review 4.  The different roles of ER subtypes in cancer biology and therapy.

Authors:  Christoforos Thomas; Jan-Åke Gustafsson
Journal:  Nat Rev Cancer       Date:  2011-07-22       Impact factor: 60.716

5.  Constitutive Activation of PI3K in Oocyte Induces Ovarian Granulosa Cell Tumors.

Authors:  So-Youn Kim; Katherine Ebbert; Marilia H Cordeiro; Megan M Romero; Kelly A Whelan; Adrian A Suarez; Teresa K Woodruff; Takeshi Kurita
Journal:  Cancer Res       Date:  2016-05-09       Impact factor: 12.701

6.  Role of estrogen receptor α and β in preserving hippocampal function during aging.

Authors:  Xiaoxia Han; Kristina K Aenlle; Linda A Bean; Asha Rani; Susan L Semple-Rowland; Ashok Kumar; Thomas C Foster
Journal:  J Neurosci       Date:  2013-02-06       Impact factor: 6.167

Review 7.  Insights into granulosa cell tumors using spontaneous or genetically engineered mouse models.

Authors:  So-Youn Kim
Journal:  Clin Exp Reprod Med       Date:  2016-03-31

8.  Ventral prostate and mammary gland phenotype in mice with complete deletion of the ERβ gene.

Authors:  Margaret Warner; Wan-Fu Wu; Leticia Montanholi; Ivan Nalvarte; Per Antonson; Jan-Ake Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-19       Impact factor: 11.205

9.  FSH Levels Are Related to E-cadherin Expression and Subcellular Location in Nonfunctioning Pituitary Tumors.

Authors:  Anders J Kolnes; Kristin A B Øystese; Nicoleta C Olarescu; Geir Ringstad; Jon Berg-Johnsen; Olivera Casar-Borota; Jens Bollerslev; Anders P Jørgensen
Journal:  J Clin Endocrinol Metab       Date:  2020-08-01       Impact factor: 5.958

Review 10.  Characterizing Endocrine Status, Tumor Hypoxia and Immunogenicity for Therapy Success in Epithelial Ovarian Cancer.

Authors:  Madison Pereira; Kathy Matuszewska; Colin Jamieson; Jim Petrik
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-17       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.